MedPath

Stromedix, Inc.

Stromedix, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2006-01-01
Employees
11
Market Cap
-
Website
http://www.stromedix.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

Phase 2
Withdrawn
Conditions
Chronic Allograft Dysfunction
First Posted Date
2009-04-09
Last Posted Date
2011-05-23
Lead Sponsor
Stromedix, Inc.
Target Recruit Count
48
Registration Number
NCT00878761
Locations
🇺🇸

Stromedix Investigative Site, Cambridge, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.